Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference23 articles.
1. Axon J, Chakravarty S, Dugar S, McEnroe G, Murphy A. P.C.T. Int. Appl. No. WO2004/024159A1, 2004.
2. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7;Byfield;Mol. Pharmacol.,2004
3. Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis;De Gouville;Br. J. Pharmacol.,2005
4. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo;Ge;Clin. Cancer Res.,2006
5. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis;Grygielko;J. Pharmacol. Exp. Ther.,2005
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献